190 related articles for article (PubMed ID: 11992304)
1. Postmenopausal estrogen replacement and risk for venous thromboembolism: a systematic review and meta-analysis for the U.S. Preventive Services Task Force.
Miller J; Chan BK; Nelson HD
Ann Intern Med; 2002 May; 136(9):680-90. PubMed ID: 11992304
[TBL] [Abstract][Full Text] [Related]
2. Postmenopausal hormone replacement therapy: scientific review.
Nelson HD; Humphrey LL; Nygren P; Teutsch SM; Allan JD
JAMA; 2002 Aug; 288(7):872-81. PubMed ID: 12186605
[TBL] [Abstract][Full Text] [Related]
3. Summaries for patients. Postmenopausal estrogen replacement therapy and the risk for blood clots: a review from the U.S. Preventive Services Task Force.
Ann Intern Med; 2002 May; 136(9):I42. PubMed ID: 11992323
[No Abstract] [Full Text] [Related]
4. Hormone replacement therapy and cognition: systematic review and meta-analysis.
LeBlanc ES; Janowsky J; Chan BK; Nelson HD
JAMA; 2001 Mar; 285(11):1489-99. PubMed ID: 11255426
[TBL] [Abstract][Full Text] [Related]
5. Risk of venous thromboembolism events in postmenopausal women using oral versus non-oral hormone therapy: A systematic review and meta-analysis.
Rovinski D; Ramos RB; Fighera TM; Casanova GK; Spritzer PM
Thromb Res; 2018 Aug; 168():83-95. PubMed ID: 29936403
[TBL] [Abstract][Full Text] [Related]
6. Long term hormone therapy for perimenopausal and postmenopausal women.
Marjoribanks J; Farquhar C; Roberts H; Lethaby A
Cochrane Database Syst Rev; 2012 Jul; (7):CD004143. PubMed ID: 22786488
[TBL] [Abstract][Full Text] [Related]
7. Hormone replacement therapy and risk of venous thromboembolism in postmenopausal women: systematic review and meta-analysis.
Canonico M; Plu-Bureau G; Lowe GD; Scarabin PY
BMJ; 2008 May; 336(7655):1227-31. PubMed ID: 18495631
[TBL] [Abstract][Full Text] [Related]
8. Menopausal hormone therapy for the primary prevention of chronic conditions: a systematic review to update the U.S. Preventive Services Task Force recommendations.
Nelson HD; Walker M; Zakher B; Mitchell J
Ann Intern Med; 2012 Jul; 157(2):104-13. PubMed ID: 22786830
[TBL] [Abstract][Full Text] [Related]
9. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Women: Evidence Report and Systematic Review for the US Preventive Services Task Force.
Gartlehner G; Patel SV; Feltner C; Weber RP; Long R; Mullican K; Boland E; Lux L; Viswanathan M
JAMA; 2017 Dec; 318(22):2234-2249. PubMed ID: 29234813
[TBL] [Abstract][Full Text] [Related]
10. [From the Cochrane Library: postmenopausal hormone replacement therapy (HRT) does not protect women against cardiovascular disease but does lead to an increased risk of venous thromboembolism].
Hamerlynck JV; Middeldorp S; Scholten RJ
Ned Tijdschr Geneeskd; 2006 Mar; 150(10):546-8. PubMed ID: 16566418
[TBL] [Abstract][Full Text] [Related]
11. The effect and safety of postmenopausal hormone therapy and selective estrogen receptor modulators on kidney outcomes in women: a protocol for systematic review and meta-analysis.
Dumanski SM; Ramesh S; James MT; Metcalfe A; Nerenberg K; Seely EW; Robertson HL; Ahmed SB
Syst Rev; 2017 Jul; 6(1):134. PubMed ID: 28683787
[TBL] [Abstract][Full Text] [Related]
12. Commonly used types of postmenopausal estrogen for treatment of hot flashes: scientific review.
Nelson HD
JAMA; 2004 Apr; 291(13):1610-20. PubMed ID: 15069049
[TBL] [Abstract][Full Text] [Related]
13. Factor V Leiden mutation and the risks for thromboembolic disease: a clinical perspective.
Price DT; Ridker PM
Ann Intern Med; 1997 Nov; 127(10):895-903. PubMed ID: 9382368
[TBL] [Abstract][Full Text] [Related]
14. Bias from depletion of susceptibles: the example of hormone replacement therapy and the risk of venous thromboembolism.
Renoux C; Dell'Aniello S; Brenner B; Suissa S
Pharmacoepidemiol Drug Saf; 2017 May; 26(5):554-560. PubMed ID: 28326633
[TBL] [Abstract][Full Text] [Related]
15. Postmenopausal hormone therapy increases risk for venous thromboembolic disease. The Heart and Estrogen/progestin Replacement Study.
Grady D; Wenger NK; Herrington D; Khan S; Furberg C; Hunninghake D; Vittinghoff E; Hulley S
Ann Intern Med; 2000 May; 132(9):689-96. PubMed ID: 10787361
[TBL] [Abstract][Full Text] [Related]
16. Hormone replacement therapy and risk of venous thromboembolism: population based case-control study.
Pérez Gutthann S; García Rodríguez LA; Castellsague J; Duque Oliart A
BMJ; 1997 Mar; 314(7083):796-800. PubMed ID: 9081000
[TBL] [Abstract][Full Text] [Related]
17. Hormone therapy for preventing cardiovascular disease in post-menopausal women.
Main C; Knight B; Moxham T; Gabriel Sanchez R; Sanchez Gomez LM; Roqué i Figuls M; Bonfill Cosp X
Cochrane Database Syst Rev; 2013 Apr; (4):CD002229. PubMed ID: 23633307
[TBL] [Abstract][Full Text] [Related]
18. Hormone Therapy for the Primary Prevention of Chronic Conditions in Postmenopausal Persons: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Gartlehner G; Patel SV; Reddy S; Rains C; Schwimmer M; Kahwati L
JAMA; 2022 Nov; 328(17):1747-1765. PubMed ID: 36318128
[TBL] [Abstract][Full Text] [Related]
19.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
20.
; ; . PubMed ID:
[No Abstract] [Full Text] [Related]
[Next] [New Search]
